Trial
NCT00539188
N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Yale University
Collaborators
—
Condition
Borderline Personality Disorder
Intervention
N-Acetylcysteine
Why stopped
Study terminated due to poor subject compliance.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-04-15